Ascentage Pharma Group International Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| POINT72 ASSET MANAGEMENT, L.P. | 05/15/2026 | 16.06 K | $383.26 K | -4.01% | 0.02% |
| XY CAPITAL LTD | 05/12/2026 | 13.01 K | $310.64 K | -4.51% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 05/15/2026 | 518 | $12.37 K | 125.22% | 0.00% |
| MORGAN STANLEY | 05/15/2026 | 498 | $11.89 K | 225.49% | 0.00% |
| UBS GROUP AG | 05/05/2026 | 124 | $2.96 K | -97.07% | 0.00% |
| EVERSOURCE WEALTH ADVISORS, LLC | 05/18/2026 | 24 | $573 | 0.00% | 0.00% |
| BANK OF AMERICA CORP /DE/ | 05/18/2026 | 0 | $0 | -100.00% | 0.00% |
| CITADEL ADVISORS LLC | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| MIRAE ASSET GLOBAL INVESTMENTS CO., LTD. | 05/04/2026 | 0 | $0 | -100.00% | 0.00% |
| ADVISOR GROUP HOLDINGS, INC. | 05/15/2026 | 0 | $0 | -100.00% | 0.00% |
| BELL INVESTMENT ADVISORS, INC | 04/17/2026 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Ascentage Pharma Group International institutional Ownership - FAQ's
During the previous two years, 12 institutional investors and hedge funds held shares of Ascentage Pharma Group International. The most heavily invested institutionals were:
Point72 Asset Management, L.P.: 16,056
XY Capital Ltd: 13,014
Tower Research Capital LLC (TRC): 518
MORGAN STANLEY: 498
UBS Group AG: 124
EverSource Wealth Advisors, LLC: 24
0.03% of Ascentage Pharma Group International stock is owned by institutional investors.
Institutional investors have bought a total of 48.16 K shares in the last 24 months. This purchase volume represents approximately $1.14 M in transactions.